Step 1 topics → General Pharmacology → Indirect Sympathomimetics

Indirect Sympathomimetics

USMLE Step 1 trap: Confuses cocaine's reuptake-blocking mechanism with amphetamine's active NE-releasing mechanism. Cocaine blocks the reuptake transporter (NET) to increase synaptic NE/dopamine; amphetamines additionally reverse the transporter to actively release NE from the terminal.

Indirect sympathomimetics don't bind adrenergic receptors directly — they work by increasing the amount of norepinephrine (and sometimes dopamine) in the synapse, and USMLE Step 1 tests this at the intersection of basic pharmacology and high-stakes clinical management. The key agents are cocaine, amphetamines, ephedrine, and tyramine, and each has a slightly different mechanism for getting there. Knowing the mechanism isn't enough on Step 1 if you can't apply it to a cocaine chest pain vignette or a patient crashing after eating aged cheese on an MAOI.

The exam tests this from three angles: pure mechanism recall (what exactly does cocaine do versus amphetamine?), clinical management (what do you give — and critically, what do you avoid — in cocaine-induced chest pain?), and clinical correlate reasoning (why does tyramine only cause a hypertensive crisis in someone on an MAOI?). Passage-based questions will give you a pharmacology experiment or a patient scenario and expect you to reason from mechanism to outcome, not just pattern-match a drug name.

The trickiest part is that students collapse all indirect sympathomimetics into one vague category of 'releases NE' — but cocaine does NOT release NE, it blocks reuptake. Amphetamines do both: they block and reverse the transporter. Tyramine displaces NE from vesicles via VMAT2. These distinctions are directly tested on USMLE Step 1, and confusing them leads to wrong answers on both mechanism questions and clinical management scenarios.

From real student decks
73%have cards covering this topic
51%have mature cards

Common misconceptions

Common mistake
Wrong: Cocaine acts like amphetamine by releasing NE from presynaptic terminals.
Right: Cocaine blocks the reuptake transporter (NET) to increase synaptic NE/dopamine; amphetamines additionally reverse the transporter to actively release NE from the terminal.
Cocaine is purely a reuptake blocker — it sits on the norepinephrine transporter (NET) and prevents NE and dopamine from being cleared from the synapse, so levels build up passively. Amphetamines go a step further: they not only block NET but actively reverse it, pumping NE out of the presynaptic terminal into the synapse — this is why amphetamine toxicity produces more dramatic NE surges. Knowing this distinction matters because exam questions will ask you to predict what happens when you deplete presynaptic NE stores: cocaine's effect is blunted (less NE available to linger), but amphetamine's is blunted too since it needs stored NE to reverse-release.
Common mistake
Wrong: Beta-blockers are appropriate for cocaine-induced chest pain because they reduce heart rate and myocardial oxygen demand.
Right: Beta-blockers are contraindicated in cocaine chest pain because unopposed alpha-1 stimulation worsens coronary vasospasm; benzodiazepines and nitroglycerin are preferred.
The instinct to give beta-blockers for chest pain with tachycardia and hypertension is usually correct — but cocaine is the major exception. Cocaine causes alpha-1-mediated coronary vasospasm in addition to beta-1-driven tachycardia. If you block beta receptors without blocking alpha, you leave alpha-1 stimulation completely unopposed, worsening coronary vasoconstriction and potentially precipitating MI. The correct approach is benzodiazepines (reduce central sympathetic drive) and nitroglycerin (vasodilate coronaries), which address the vasospasm without the rebound alpha problem.
Common mistake
Wrong: Tyramine directly stimulates adrenergic receptors to cause hypertensive crisis in MAOI users.
Right: Tyramine is an indirect sympathomimetic that displaces NE from presynaptic vesicles; MAO normally degrades tyramine in the gut/liver, so MAOI use allows massive NE release and hypertensive crisis.
Tyramine doesn't touch adrenergic receptors — it works indirectly by entering the presynaptic terminal and displacing NE from storage vesicles (via VMAT2 competition), dumping NE into the synapse. Normally, MAO in the gut wall and liver destroys most dietary tyramine before it ever reaches systemic circulation — this is called the 'cheese effect' protection. When a patient is on an MAOI, that first-pass destruction is gone, tyramine floods the system, massive NE release follows, and the result is a hypertensive crisis. The fix is phentolamine (alpha blocker) or nitroprusside, not something targeting the receptor directly.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the specific mechanism for each indirect sympathomimetic: cocaine blocks NET (reuptake inhibition only), amphetamines block NET and reverse it to actively dump NE into the synapse, ephedrine displaces NE from terminals, and tyramine displaces NE from presynaptic vesicles by interfering with VMAT2.
  2. Given a patient with cocaine-induced chest pain, identify the correct management — benzodiazepines and nitroglycerin — and explain why beta-blockers are specifically contraindicated due to the risk of unopposed alpha-1-mediated coronary vasospasm.
  3. Explain the MAOI-tyramine hypertensive crisis mechanistically: tyramine is normally destroyed by MAO in the gut and liver before it reaches systemic circulation, so MAOI use allows massive tyramine absorption, leading to huge NE displacement and a sympathetic surge.

Can you avoid these mistakes?

A researcher depletes presynaptic NE stores with reserpine, then applies cocaine and amphetamine separately to nerve terminals. Which drug loses more of its effect, and why?
A 28-year-old man presents with chest pain, hypertension (BP 190/110), and tachycardia after cocaine use. An intern recommends metoprolol. What is the specific danger of this choice, and what should you give instead?
A patient on phenelzine eats a large amount of aged cheddar and develops a pounding headache, BP of 210/130, and diaphoresis. Walk through the mechanism: what did the tyramine do, why was the crisis so severe, and what drug class would you use to treat the acute hypertension?
Ephedrine is used to treat hypotension during spinal anesthesia. Why does its effect diminish with repeated dosing, and which drug would NOT show this same tachyphylaxis?

Related topics

Adrenergic Agonists (Direct) ADME and Bioavailability Volume of Distribution (Vd) Clearance and Half-Life First-Order vs Zero-Order Elimination

See how your Anki deck covers this topic.

Upload your deck for a free audit →